Persistence of fibrogenic process in direct-acting antiviral (DAA) treated patients? | ELSPublishing

Letter

Open Access

Cite

Expand

Persistence of fibrogenic process in direct-acting antiviral (DAA) treated patients?

Cecilia Battistelli¹, Marco Tripodi^1,²^,∗

¹ Sapienza University of Rome, Department of Molecular Medicine, Rome, Italy

² National Institute for Infectious Diseases “L. Spallanzani”, Rome, Italy

* marco.tripodi@uniroma1.it

Volume
Volume 4 Issue 2, 2022
Citation
Battistelli C, Tripodi M. Persistence of fibrogenic process in direct-acting antiviral (DAA) treated patients?. ExRNA 2022(2):0007, https://doi.org/10.21037/exrna-22-13.
DOI
10.21037/exrna-22-13
Copyright
Copyright2022 by the authors. Published by ELSP.

Preview